228 related articles for article (PubMed ID: 31960952)
1. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients.
Bonfrate L; Di Palo DM; Celano G; Albert A; Vitellio P; De Angelis M; Gobbetti M; Portincasa P
Eur J Clin Invest; 2020 Mar; 50(3):e13201. PubMed ID: 31960952
[TBL] [Abstract][Full Text] [Related]
2. Effect of
Toscano M; De Grandi R; Stronati L; De Vecchi E; Drago L
World J Gastroenterol; 2017 Apr; 23(15):2696-2704. PubMed ID: 28487606
[TBL] [Abstract][Full Text] [Related]
3. Effects of
Vitellio P; Celano G; Bonfrate L; Gobbetti M; Portincasa P; De Angelis M
Nutrients; 2019 Apr; 11(4):. PubMed ID: 31010241
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live
Srivastava S; Basak U; Naghibi M; Vijayakumar V; Parihar R; Patel J; Jadon PS; Pandit A; Dargad RR; Khanna S; Kumar S; Day R
Gut Microbes; 2024; 16(1):2338322. PubMed ID: 38630015
[TBL] [Abstract][Full Text] [Related]
5. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of
Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
[TBL] [Abstract][Full Text] [Related]
7. Growth and adhesion to HT-29 cells inhibition of Gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination.
Inturri R; Stivala A; Furneri PM; Blandino G
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4943-4949. PubMed ID: 27981539
[TBL] [Abstract][Full Text] [Related]
8. Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination.
Inturri R; Stivala A; Blandino G
Minerva Gastroenterol Dietol; 2015 Dec; 61(4):191-7. PubMed ID: 26657925
[TBL] [Abstract][Full Text] [Related]
9. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
10. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
[TBL] [Abstract][Full Text] [Related]
11. Effect of
Sabaté JM; Iglicki F
World J Gastroenterol; 2022 Feb; 28(7):732-744. PubMed ID: 35317278
[TBL] [Abstract][Full Text] [Related]
12. Integrated gut microbiome and metabolome analyses identified fecal biomarkers for bowel movement regulation by
Nakamura Y; Suzuki S; Murakami S; Nishimoto Y; Higashi K; Watarai N; Umetsu J; Ishii C; Ito Y; Mori Y; Kohno M; Yamada T; Fukuda S
Comput Struct Biotechnol J; 2022; 20():5847-5858. PubMed ID: 36382178
[TBL] [Abstract][Full Text] [Related]
13. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
Dapoigny M; Piche T; Ducrotte P; Lunaud B; Cardot JM; Bernalier-Donadille A
World J Gastroenterol; 2012 May; 18(17):2067-75. PubMed ID: 22563194
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
Drozdov VN; Shikh EV; Astapovskii AA; Khalaidzheva KN; Solovieva SA; Dorogun OB
Vopr Pitan; 2023; 92(4):92-103. PubMed ID: 37801459
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S; Mora D; Gschwender M; Popp K
Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
[TBL] [Abstract][Full Text] [Related]
17. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
18. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
[TBL] [Abstract][Full Text] [Related]
19. Selenium-enriched
Jin X; Hu Y; Lin T; Gao F; Xu Z; Hou X; Yin Y; Kan S; Zhu H; Chen D
Food Funct; 2023 Jun; 14(11):5355-5374. PubMed ID: 37212199
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
